↓ Skip to main content

Aripiprazole-induced sleep-related eating disorder: a case report

Overview of attention for article published in Journal of Medical Case Reports, April 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

blogs
1 blog
twitter
2 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
48 Mendeley
Title
Aripiprazole-induced sleep-related eating disorder: a case report
Published in
Journal of Medical Case Reports, April 2018
DOI 10.1186/s13256-018-1622-2
Pubmed ID
Authors

Nobuyuki Kobayashi, Masahiro Takano

Abstract

Sleep-related eating disorder is characterized by parasomnia with recurrent episodes of nocturnal eating or drinking during the main sleep period. Several drugs, including atypical antipsychotics, induce sleep-related eating disorder. However, aripiprazole has not previously been associated with sleep-related eating disorder. A 41-year-old Japanese man visited our clinic complaining of depression. The patient was treated with sertraline, which was titrated up to 100 mg for 4 weeks. A sleep inducer and an anxiolytic were coadministered. His depressive mood slightly improved, but it continued for an additional 4 months. Subsequently, aripiprazole (3 mg) was added as an adjunctive therapy. After 3 weeks, the patient's mother found that the patient woke up and ate food at night. The next morning, the patient was amnesic for this event, felt full, and wondered why the bags of food were empty. This episode lasted for 2 days. The patient gained 5 kg during these 3 weeks. After the aripiprazole dose was reduced to 1.5 mg, the patient's nocturnal eating episodes rapidly and completely disappeared. To the best of our knowledge, this is first report of sleep-related eating disorder induced by aripiprazole, and it indicates that this disorder should be considered a possible side effect of aripiprazole. Although aripiprazole is used mainly in patients with schizophrenia, its recently documented use as an adjunctive therapy in patients with depression might induce hitherto unknown side effects.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 17%
Researcher 4 8%
Student > Ph. D. Student 3 6%
Student > Master 3 6%
Other 2 4%
Other 7 15%
Unknown 21 44%
Readers by discipline Count As %
Medicine and Dentistry 13 27%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Psychology 2 4%
Neuroscience 2 4%
Sports and Recreations 1 2%
Other 3 6%
Unknown 24 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 August 2022.
All research outputs
#4,141,516
of 25,210,618 outputs
Outputs from Journal of Medical Case Reports
#345
of 4,497 outputs
Outputs of similar age
#75,092
of 335,507 outputs
Outputs of similar age from Journal of Medical Case Reports
#5
of 78 outputs
Altmetric has tracked 25,210,618 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,497 research outputs from this source. They receive a mean Attention Score of 4.0. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 335,507 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 78 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.